Vimarsana
Biggest News Aggregation in the World

Medical Needs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medical Needs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medical Needs Today - Breaking & Trending Today

Community Notes - Vimarsana News

Community Notes

COMMUNITY NOTES may be submitted for non-profit, civic or church-related events and published free of charge AS SPACE IS AVAILABLE in the Courier Journal. Community Notes must be submitted in

Tibsovo Market Expected to Surge with a CAGR of Approximately 5.1% by 2030 - Vimarsana News

Tibsovo Market Expected to Surge with a CAGR of Approximately 5.1% by 2030

Market OverviewTibsovo (ivosidenib) is a targeted cancer therapy developed by Agios Pharmaceuticals, Inc. It is an oral, small molecule inhibitor of the isocitrate dehydrogenase 1 (IDH1) enzyme, which is mutated in various types of cancers, including acute myeloid leukemia (AML), cholangiocarcinoma, and glioma. Tibs...

Tax, savings for senior citizens: NITI Aayog pitches for tax reforms, plans for elderly - Vimarsana News

Tax, savings for senior citizens: NITI Aayog pitches for tax reforms, plans for elderly

In its comprehensive report, NITI Aayog has highlighted the need to cultivate a robust environment for senior care services. The key strategies proposed include implementing a reverse mortgage mechanism aimed at enhancing financial liquidity for seniors. Further recommendations encompass mandatory savings plans, and tax and GST reforms on senior care products.

Tristan Thompson Reveals 17-Year-Old Disabled Brother's Medical Needs in Plea to Be Named Guardian - Vimarsana News

Tristan Thompson Reveals 17-Year-Old Disabled Brother's Medical Needs in Plea to Be Named Guardian

The NBA star slammed his father Trevor for abandoning the family and failing to pay child support.

Eisai: Antiepileptic Drug Fycompa Injection Formulation Approved In Japan - Vimarsana News

Eisai: Antiepileptic Drug Fycompa Injection Formulation Approved In Japan

Addressing Medical Needs for Treatment Through a Non-Oral Administration Route TOKYO, Jan 18, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has obtained marketing authorization approval from the Japanese Ministry of Health, Labour and ...